glp 1 agonist in ckd GLP1 Receptor Agonists vs SGLT2-I Preventing in T2DM: An Interview – AJKD Blog image3.png
Description
Drugs Today 47 , 99107 (2011)
IRE1XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain
Indian J Psychol Med
These medications were initially created to treat type 2 diabetes and have been extensively researched for several decades
Scientists identified GLP-1 in 1986
FIGURE 3 Taken together, these mechanistic data and large-scale epidemiological findings point to a possible protective effect of GLP-1RAs against selected OACs
